Pakistan's pharmaceutical industry, valued at Rs. 748 billion, faces challenges with API imports. Localizing API production ...
India Ratings (Ind-Ra) predicts a recovery in API prices for FY27, driven by India's Minimum Import Price (MIP) and China’s ...
The FDA released a warning letter sent to Chinese API maker Qinhuangdao Zizhu Pharmaceutical in April that outlined data integrity problems at the company’s Hebei province facility following an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results